[ASND] QoQ Quarter Result on 30-Sep-2019 [#Q3]

Stock
[ASND] Ascendis Pharma A/S
Announcement Date
28-Aug-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- 57.37%
YoY- 26.07%
Quarter Report
ASND's Result
ASND's Financial Summary
View:
Show?
Quarter Result
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Revenue 1,436 2,225 2,507 2,243 3,211 5,414 10,515 -73.51%
PBT -95,038 -63,394 -80,400 -25,174 -58,969 -53,707 -32,066 106.46%
Tax -106 -77 -38 -61 -65 -70 -88 13.22%
NP -94,932 -63,317 -80,362 -25,113 -58,904 -53,637 -31,978 106.69%
Tax Rate - - - - - - - -
Total Cost 96,368 65,542 82,869 27,356 62,115 59,051 42,493 72.70%
Ratio Analysis
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
NP Margin -6,610.86 -2,845.71 -3,205.50 -1,119.62 -1,834.44 -990.71 -304.12 680.35%
Per Share
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
EPS -1.97 -1.32 -1.68 -0.53 -1.25 -1.24 -0.76 88.80%
EPS Diluted -1.97 -1.32 -1.67 -0.53 -1.25 -1.24 -0.74 92.19%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.